JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma	B-Non Hodgkin Lymphoma	Not yet recruiting	Not applicable	2025-03-17		NCT06879470

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
He Huang	12

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Zhejiang University school of medicine	Hangzhou	China	18

Clinical trials